Table 1. Proteasome inhibitors.
| Compound/Origin (if natural) | Activity, IC50, nM | Type of assay | Ref. | ||
|---|---|---|---|---|---|
| CT-L | T-L | C-L | |||
| Peptide aldehydes | |||||
| Felutamide B (Penicillium fellutanum) | 9.4 | 2000 | 1200 | 20S | [65] |
| TP-110 | 27 | 20S | [66] | ||
| MG132 | 68 | 4500 | 1400 | 20S | [66] |
| Tyropeptin A (Kitasabospora sp.) | 40 | 20S | [65] | ||
| 1400 | 5000 | 68 000 | 20S | [66] | |
| Dose-dependent | PC12 cells | [67] | |||
| Syrbactins | |||||
| Glidobactin A (Burkholderiales) | 15 | >15 | 20S | [68] | |
| Syringolin A (Pseudomona syringae) | 1300 | >1300 | >1300 | 20S | [68] |
| Epoxyketones | |||||
| Epoxomicin (Actinomycetes) | 5.7 | 20S | [65] | ||
| NC-022 | 300 | 20S | [69] | ||
| NC-001 | 500 | MM1.R, NCI-H929 | [70] | ||
| YU-102 | + | 20S | [71] | ||
| Vinyl esters | |||||
| HMB-LLL-VE | 41 | 4210 | >10 000 | 20S | [72] |
| Peptide Vinyl Sulfones | |||||
| MB1 | + | 20S | [73] | ||
| Natural polyphenols | |||||
| Epigallocatechin gallate / EGCG (tea polyphenols) | 86–194 | 20S | [74] | ||
| 1000–10000 | Living Jurkat T cells | [75] | |||
| Curcumin / diferuloylmethane (Curcuma longa) | 1850 | 6230 | 3680 | 20S | [76] |
| 20000 | HCT-116 and SW480 cells | [76] | |||
| Natural cationic porphyrins | |||||
| H2T4 | 750 | 530 | 460 | 20S and 26S | [77] |
| β-lactones | |||||
| Omuralide / clasto-lactacystin-β-lactone (Salinospora tropica) | 29 | 690 | 8300 | 20S | [78] |
| 600 | Living Jurkat T cells | [75] | |||
| Hydronaphthoquinones | |||||
| PI-083 | 1000 | 4500 | 4500 | 20S | [79] |
| > 1000 | > 4500 | > 4500 | Nude mice | [79] | |
| Isothiocyanates | |||||
| BITC | 4700 | ~10000 | ~10000 | A549 cells | [80] |
| Triterpenoids | |||||
| Pristimerin (Celastrus Maytenus) | <100 | 20S | [81] | ||
| 50 000 | H929 and U266 U266 cells | [81] | |||
| Celastrol (Tripterygium Wilfordi, Celastrus Regelii) | 2500 | A6 Xenopus cells, mammalian cells, human prostate cancer cells | [82] | ||
| 1000–5000 | Nude mice PC-3 or LNCaP cells | [83] | |||
| Chalcones | |||||
| AM114 | 1000 | 20S | [84] | ||
| 1490 | HCT116 p53 +/+ cells | [84] | |||
| Imidazoline derivatives | |||||
| TCH-013 | 2800 | 1600 | 20S | [85] | |
| Carbamides and carbamates | |||||
| Hydroxyurea | 1000 | 20S | [86] | ||
| DSF / disulfiram | 2000 | MDA-MB-231 cells | [87] | ||
| DSF Cu (II) | 7500 | 20S | [88] | ||
| >7500 | 26S | [88] | |||
| DSF Cd | 3500 | 20S | [88] | ||
| 3200 | hMCF 10 DCIS cells and PC-3 cells | [87] | |||
| Inorganics | |||||
| CuCl2 | 5100 | 20S | [89] | ||
A summary of proteasome inhibitors known to-date grouped by: their origin (synthetic or natural), targeting specificity and IC50 against the proteasomal enzymatic activities (CT-L stands for ChymoTrypsin-Like, T-L stands for Trypsin-Like and C-L stands for Caspase-Like activity), and type of assay used for measuring the inhibitory effect. The compounds are also divided into classes according to their chemical structures (aldehydes, syrbactins, epoxyketones, etc.).